An Efficacy and Safety Study of Sodium Oligomannate (GV-971) for the Treatment of Alzheimer's Disease
Clinical trial NCT05908695 · RECRUITING
Trial details
- NCT number
- NCT05908695
- Sponsor
- Green Valley (Shanghai) Pharmaceuticals Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-31
- Primary completion
- 2029-06-01
- Enrollment
- 1312
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.